ELEV News and Press, Elevation Oncology Inc. From 08/16/23

Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021 PR Newswire NEW YORK , Aug. 16, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of sele...

2023-08-03 10:31:29 ET Elevation Oncology press release ( NASDAQ: ELEV ): Q2 GAAP EPS of -$0.37. As of June 30, 2023, Elevation Oncology had cash, cash equivalents and marketable securities totaling $107.9 million, inclusive of net proceeds from the underwritte...

Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements PR Newswire Initial Phase 1 SYSA1801 (EO-3021) data presented by partner CSPC Pharmaceutical Group Limited at ASCO 2023 showed promising signs of efficacy, inclu...

2023-07-13 08:58:37 ET Innovative oncology company Elevation Oncology ( NASDAQ: ELEV ), appoints Joseph Ferra as its CEO. Mr. Ferra was previously interim CEO and CFO. Mr. Ferra will also join the Elevation Oncology Board of Directors. In addition, ...

Elevation Oncology Appoints Joseph Ferra as Chief Executive Officer and Promotes Tammy Furlong to Chief Financial Officer PR Newswire NEW YORK , July 13, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the d...

2023-06-09 14:37:00 ET Gainers: Blue Apron Holdings ( APRN ) +65% . Sientra ( SIEN ) +50% . ContraFect ( CFRX ) +43% . Global Indemnity ( GBLI ) +23% . Disc Medicine Opco ( IRON ) +21% . Olema Pharmaceuticals ( OLMA ) +...

2023-06-09 10:07:38 ET Gainers: Sientra ( SIEN ) +65% . ContraFect ( CFRX ) +47% . Societal CDMO ( SCTL ) +20% . Akili ( AKLI ) +14% . Erasca ( ERAS ) +12% . Losers: Elevation Oncology ( ELEV ) -41% . Longboar...

2023-06-09 02:52:00 ET Innovative oncology company, Elevation Oncology ( ELEV ) stock drops 25% as it proposes public offering of stock and warrants. The c ompany prices 17.81M shares and pre-funded warrants to purchase up to an aggregate of 4.44M shares; accomp...

Elevation Oncology Announces Pricing of $50 Million Public Offering PR Newswire NEW YORK , June 8, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies ...

2023-06-08 18:08:17 ET Gainers: Sientra ( SIEN ) +77% . Braze ( BRZE ) +10% . Expensify ( EXFY ) +7% . Jiayin Group  ( JFIN ) +6% . Mission Produce ( AVO ) +5% . Losers: Elevation Oncology ( ELEV ) -26% . ...